{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:48:25Z","timestamp":1791838105881,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.resinv.2026.101503","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:14:41Z","timestamp":1787771681000},"page":"101503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-6540","authenticated-orcid":false,"given":"Hiroaki","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Sogabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-3688","authenticated-orcid":false,"given":"Kazuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-1178","authenticated-orcid":false,"given":"Yuri","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6517-849X","authenticated-orcid":false,"given":"Mitsukuni","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeya","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yoshimine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Hanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-6833","authenticated-orcid":false,"given":"Kazunori","family":"Tobino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101503_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101503_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.7542","article-title":"Durvalumab after chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer","volume":"7","author":"Mooradian","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.resinv.2026.101503_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtho.2025.08.010","article-title":"Long-term safety and effectiveness of durvalumab in unresectable stage III NSCLC in Japan: a multicenter prospective study (AYAME)","volume":"21","author":"Kenmotsu","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/JTO.0b013e3182582912","article-title":"Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes","volume":"7","author":"Phernambucq","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cllc.2023.10.009","article-title":"Influence of tumor cavitation on assessing the clinical benefit of anti-PD1 or PD-L1 inhibitors in advanced lung squamous cell carcinoma","volume":"25","author":"Chen","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.resinv.2026.101503_bib8","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232558","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"310","author":"Bankier","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2026.101503_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/RTI.0000000000000168","article-title":"The pseudocavitation sign of lung adenocarcinoma: a distinguishing feature and imaging biomarker of lepidic growth","volume":"30","author":"Tailor","year":"2015","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.resinv.2026.101503_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.resinv.2026.101503_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-12-27","article-title":"Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy","volume":"12","author":"Ito","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.resinv.2026.101503_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4518935","article-title":"Risk factors for fatal pulmonary hemorrhage following concurrent chemoradiotherapy in stage 3B\/C squamous-cell lung carcinoma patients","volume":"2018","author":"Topkan","year":"2018","journal-title":"J Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib13","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.21037\/jtd-2025-235","article-title":"Pulmonary cavitary lesions: a captivating visual review","volume":"17","author":"Nunes","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2026.101503_bib14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/JTO.0b013e3181d899d7","article-title":"Tumor necrosis and cavitation after stereotactic body radiation therapy","volume":"5","author":"Devisetty","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2026.101503_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110652","article-title":"Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages","volume":"122","author":"Cui","year":"2023","journal-title":"Int Immunopharmacol"}],"updated-by":[{"DOI":"10.1016\/j.resinv.2026.101517","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000}}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:26:10Z","timestamp":1791501970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2212534526001371"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101503","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101503"}}